✦ LIBER ✦

Safety and Tolerability of Dimebon for up to 26 Weeks in Patients With Mild to Moderate Alzheimer's Disease

✍ Scribed by Sano, Mary; Styren, Scot; Fullerton, Terence; Brunell, Robert; Dubrava, Sarah; McRae, Tom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open label, multicenter, 28-week extensi

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB

Safety, tolerability and pharmacokinetic

✍ Arai, Heii; Umemura, Kazao; Ichimiya, Yosuke; Iseki, Eizo; Eto, Ko; Shibata, Nob 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 174 KB

A safety, tolerability and pharmacokinet

✍ Pierre Tariot; Marwan Sabbagh; Stephen Flitman; Patricio Reyes; Louise Taber; Ly 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and tolerability of BMS-708163 in

✍ Salloway, Stephen; Coric, Vlad; Brody, Mark; Andreasen, Niels; van Dyck, Christo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Long-term safety and tolerability of don

✍ Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

0706 Once-daily galantamine provides imp

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 236 KB